EiRx Therapeutics, based in Cork, said it has requested a suspension of trading in its shares on AIM, pending clarification of its financial position.

THE funding package put in place by EiRx Therapeutics is sufficient and will allow it to advance its drug development programme over the next 12 months, according to the Cork-based company.